Snowball logo
logo
EVOK_logo

Evoke Pharma Inc

EVOK β€’ NASDAQ
$28.10$0.00Β  (0%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20202021202220232024TTM
Revenue
Total revenue
0.0231.6180762.5086455.1806310.2514.42
COGS
0.08670.3281180.3703940.2018790.3565310.429769
Gross Profit
(0.0637)1.2899582.1382514.9787519.89288413.99
Operating Expenses & Income
Operating Income
(13.05)(8.151647)(7.786137)(7.430891)(5.204137)(5.191981)
Total Operating Expenses
12.989.4416059.92438812.4115.119.19
R&D Expenses
6.5548250.5904760.3007890.1819070.016316,322
Selling General & Admin Expenses
6.4288328.8511299.62359911.0315.0819.13
Earnings from Continuing Operations
Interest Expense
(0.112994)(0.50005)(0.5)(0.5)(0.50137)(0.500001)
Interest Income
0.0056720.0086150.0620.144640.3533130.465854
Income Tax Expense
0.1073220.491435(0.062)(7.430891)-2.724782
Net Income
Net Income
(13.15)(8.537952)(8.22413)(7.792295)(5.352194)(5.226128)
Supplemental
EBIT
(13.04)(8.037902)(7.72413)(7.292295)(4.850824)-
EBITDA
(13.04)(8.037902)(7.72413)(7.153699)0.353313(4.726127)
In millions of USD, except % and values per 1 share